These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 12232565)

  • 1. Cariporide for pharmacologic defibrillation after prolonged cardiac arrest.
    Wann SR; Weil MH; Sun S; Tang W; Yu T
    J Cardiovasc Pharmacol Ther; 2002 Jul; 7(3):161-9. PubMed ID: 12232565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacologic defibrillation.
    Wann SR; Weil MH; Sun S; Tang W; Pellis T
    Crit Care Med; 2002 Apr; 30(4 Suppl):S154-6. PubMed ID: 11953643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AVE4454B--a novel sodium-hydrogen exchanger isoform-1 inhibitor--compared less effective than cariporide for resuscitation from cardiac arrest.
    Radhakrishnan J; Kolarova JD; Ayoub IM; Gazmuri RJ
    Transl Res; 2011 Feb; 157(2):71-80. PubMed ID: 21256459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful ventricular defibrillation by the selective sodium-hydrogen exchanger isoform-1 inhibitor cariporide.
    Gazmuri RJ; Ayoub IM; Hoffner E; Kolarova JD
    Circulation; 2001 Jul; 104(2):234-9. PubMed ID: 11447092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epinephrine increases the severity of postresuscitation myocardial dysfunction.
    Tang W; Weil MH; Sun S; Noc M; Yang L; Gazmuri RJ
    Circulation; 1995 Nov; 92(10):3089-93. PubMed ID: 7586280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cariporide potentiates the effects of epinephrine and vasopressin by nonvascular mechanisms during closed-chest resuscitation.
    Kolarova J; Yi Z; Ayoub IM; Gazmuri RJ
    Chest; 2005 Apr; 127(4):1327-34. PubMed ID: 15821211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sodium-hydrogen exchange inhibition during ventricular fibrillation: Beneficial effects on ischemic contracture, action potential duration, reperfusion arrhythmias, myocardial function, and resuscitability.
    Ayoub IM; Kolarova J; Yi Z; Trevedi A; Deshmukh H; Lubell DL; Franz MR; Maldonado FA; Gazmuri RJ
    Circulation; 2003 Apr; 107(13):1804-9. PubMed ID: 12665493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of buffer agents on postresuscitation myocardial dysfunction.
    Sun S; Weil MH; Tang W; Fukui M
    Crit Care Med; 1996 Dec; 24(12):2035-41. PubMed ID: 8968273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cariporide minimizes adverse myocardial effects of epinephrine during resuscitation from ventricular fibrillation.
    Ayoub IM; Kolarova J; Kantola RL; Sanders R; Gazmuri RJ
    Crit Care Med; 2005 Nov; 33(11):2599-605. PubMed ID: 16276186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cariporide given during resuscitation promotes return of electrically stable and mechanically competent cardiac activity.
    Ayoub IM; Kolarova J; Gazmuri RJ
    Resuscitation; 2010 Jan; 81(1):106-10. PubMed ID: 19853351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial protection during ventricular fibrillation by inhibition of the sodium-hydrogen exchanger isoform-1.
    Gazmuri RJ; Ayoub IM; Kolarova JD; Karmazyn M
    Crit Care Med; 2002 Apr; 30(4 Suppl):S166-71. PubMed ID: 11940795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal timing for electrical defibrillation after prolonged untreated ventricular fibrillation.
    Kolarova J; Ayoub IM; Yi Z; Gazmuri RJ
    Crit Care Med; 2003 Jul; 31(7):2022-8. PubMed ID: 12847399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levosimendan improves postresuscitation outcomes in a rat model of CPR.
    Huang L; Weil MH; Sun S; Cammarata G; Cao L; Tang W
    J Lab Clin Med; 2005 Nov; 146(5):256-61. PubMed ID: 16242524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism by which activation of delta-opioid receptor reduces the severity of postresuscitation myocardial dysfunction.
    Fang X; Tang W; Sun S; Huang L; Huang Z; Weil MH
    Crit Care Med; 2006 Oct; 34(10):2607-12. PubMed ID: 16775573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved outcomes of cardiopulmonary resuscitation in rats with myocardial infarction treated with allogenic bone marrow mesenchymal stem cells.
    Wang T; Tang W; Sun S; Ristagno G; Xu T; Weil MH
    Crit Care Med; 2009 Mar; 37(3):833-9. PubMed ID: 19237885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carvedilol mitigates adverse effects of epinephrine during cardiopulmonary resuscitation.
    Huang L; Weil MH; Sun S; Tang W; Fang X
    J Cardiovasc Pharmacol Ther; 2005 Jun; 10(2):113-20. PubMed ID: 15965562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diastolic dysfunction in stunned myocardium: a state of abnormal excitation-contraction coupling that is limited by Na+-H+ exchange inhibition.
    Castellá M; Buckberg GD; Saleh S
    Eur J Cardiothorac Surg; 2006 Apr; 29 Suppl 1():S107-14. PubMed ID: 16564695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-dependent reduction of myocardial infarct mass in rabbits by the NHE-1 inhibitor cariporide (HOE 642).
    Linz W; Albus U; Crause P; Jung W; Weichert A; Schölkens BA; Scholz W
    Clin Exp Hypertens; 1998 Oct; 20(7):733-49. PubMed ID: 9764718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental studies on myocardial protection with intermittent cross-clamp fibrillation: additive effect of the sodium-hydrogen exchanger inhibitor, cariporide.
    Fujii M; Avkiran M; Chambers DJ
    Ann Thorac Surg; 2004 Apr; 77(4):1398-407. PubMed ID: 15063274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A lazaroid mitigates postresuscitation myocardial dysfunction.
    Wang J; Weil MH; Kamohara T; Tang W; Sun S; Klouche K; Bisera J
    Crit Care Med; 2004 Feb; 32(2):553-8. PubMed ID: 14758178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.